Listeria monocytogenes is a cancer immunotherapy vector that increases the strength of anti-tumor activities through CD8+ and CD4+ lymphocytes, crossing epithelial living layers and stimulating the immune system. The gene discussed is CD8A; the disease is neoplasm.